Citation: | ZHANG Jie, CHI Huibo, CHENG Yanju, CAO Feng. Ophthalmic solution of thiolated chitosan-pirenoxine sodium-layered double hydroxides hybrid nanocomposites[J]. Journal of China Pharmaceutical University, 2015, 46(2): 201-208. DOI: 10.11665/j.issn.1000-5048.20150211 |
[1] |
Allmann R.The crystal structure of pyroaurite[J].Acta Crystallogr B,1986(24):972-977.
|
[2] |
Rives V,Arco MD,Martn C.Layered double hydroxides as drug carriers and for controlled non-steroid:a review[J].J Control Release,2013,168(1/2):28-39.
|
[3] |
Chakrabortia M,Jacksona JK,Plackettb D,et al.Drug intercalation in layered double hydroxide clay:application in the development of a nanocomposite film for guided tissue regeneration[J].Int J Pharm,2011,416(2):305-313.
|
[4] |
Zhang XQ,Zeng MG,Li SP,et al,Methotrexate intercalated layered double hydroxides with differentparticle sizes:structural study and controlled release properties[J].Colloid Surf B:Biointerfaces,2014,117(1):98-106.
|
[5] |
Berber MR.,Hafez IH,Minagawa K,et al.Nanocomposite formulation system of lipid-regulating drugs based on layered double hydroxide:synthesis,characterization and drug release properties[J].Pharm Res,2010,27(11):2394-2401.
|
[6] |
Rives V,Arco MD,Martin C.Intercalation of drugs in layered double hydroxides and their controlled release[J].App Clay Sci,2014(89):239-269.
|
[7] |
Kafedjiiski K, Foger F, Werle M, et al. Synthesis and in vitro evaluation of a novel chitosan-glutathione conjugate[J].Pharm Res,2005,22(9):1480-1488.
|
[8] |
Ylenia Z,Francesca F,Angela F,et al.Mucoadhesive nanoparticles made of thiolated quaternary chitosan crosslinked with hyaluronan[J].Carbohydr Polym,2013,92(1):33-39.
|
[9] |
Miriam C,Salvatore S,Marcella C.Pirenoxine prevents oxidative effects of argon fluoride excimer laser irradiation in rabbit corneas:biochemical,histological and cytofluorimetric evaluations[J].J Photoch Photobiol B,2005,78(1):35-42.
|
[10] |
Chennamaneni SR,Mamalis C,Archer B,et al.Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation[J].J Control Release,2013,167(1):53-59.
|
[11] |
Cao F, Wang YJ, Ping QN, et al. Zn-Al-NO3-layered double hydroxides with intercalated diclofenac for ocular delivery[J].Int J Pharm,2011,404(1/2):250-256.
|
[12] |
Jin XF,Xu Y,Shen J,et al.Chitosan-glutathione conjugate-coated poly(butyl cyanoacrylate)nanoparticles:promising carriers for oral thymopentin delivery[J].Carbohydr Polym,2011,86(1):51-57.
|
[13] |
Wang YJ,Cao F,Ping QN.Preparation and characterization of diclofenac sodium layered double hydroxide nanohybrids[J].J China Pharm Univ(中国药科大学学报),2009,40(4):321-326.
|
[14] |
Yong L,Wang A,Ping X,et al.Structural and spectroscopic study of tripeptide/layered double hydroxide hybrids[J].J Colloid Interf Sci,2013(394):564-572.
|
[15] |
Chinese Pharmacopoeia Commission.Drug Standard of Ministry of Public Health of the People′s Republic of China:Part 2(中华人民共和国卫生部药品标准:二部)[S].Beijing:Chemical Industry Press,1995:46-48.
|
[16] |
Kong CX,Zhang Q,Liu YN,et al.Determination of Pirenoxine sodium and its related substances by HPLC[J].China Pharm(中国药师),2013,16(1):66-69.
|
[17] |
Zhu HG, Tang PG, Feng YJ. Intercalation of IR absorber into layered double hydroxides:preparation,thermal stability and selective IR absorption[J].Mater Res Bull,2012,47(3):532-536.
|
[18] |
Kuk WK,Huh YD.Preferential intercalation of isomers of anthraquinone sulfonate ions into layered double hydroxides[J].J Mater Chem,1997,7(9):1933-1936.
|
[19] |
Amrite AC,Eeelhauser HF,Singh SR,et al.Effect of circulation on the disposition and ocular tissue distribution of nanoparticles after periocular administration[J].Mol Vis,2008,14(29):150-160.
|
[20] |
Li Y,Ni ZM,Xu Q,et al.Molecular dynamics simulation of histidine intercalated Zn/Al hydrotalcite and releasen course[J].J Chin Ceram Soc(硅酸盐学报),2011,1(39):63-68.
|
[21] |
Qin ZG,Cao F,Ping QN,et al.Layered double hydroxides and their applications in drug delivery systems[J].Prog Pharm Sci(药学进展),2013,37(12):615-622.
|
[1] | XU Linhao, LIU Xinze, LIU Wei, XIANG Ping, HANG Taijun, YANG Shuo, YAN Hui. Application of zebrafish model in the metabolism of new psychoactive substances[J]. Journal of China Pharmaceutical University, 2022, 53(5): 606-612. DOI: 10.11665/j.issn.1000-5048.20220511 |
[2] | CHENG Liyuan, LIU Wei, GUO Xiaoyan, GE Xiaoai, WANG Dingding, WANG Tao. Effects and mechanism of zidovudine on glucolipid metabolic balance in mice[J]. Journal of China Pharmaceutical University, 2022, 53(3): 340-347. DOI: 10.11665/j.issn.1000-5048.20220312 |
[3] | WANG Jingqi, WANG Ye, ZHANG Yi, LIANG Juncheng, DENG Yanping, HANG Taijun, SONG Min. Metabolomic study on clinical staging of methamphetamine detoxification by LC-QTOF-MS[J]. Journal of China Pharmaceutical University, 2022, 53(3): 314-322. DOI: 10.11665/j.issn.1000-5048.20220309 |
[4] | HE Mingzhe, PENG Ying, WANG Guangji, A Jiye, ZHENG Yiwen, SUN Jianguo. Mechanism of sodium salicylate-induced damage to HEI-OC1 cells based on metabonomics[J]. Journal of China Pharmaceutical University, 2021, 52(5): 566-572. DOI: 10.11665/j.issn.1000-5048.20210508 |
[5] | WU Yubing, YIN Lifang, QIN Chao. Clinical application and detection of matrix metalloproteinases in diagnosis[J]. Journal of China Pharmaceutical University, 2020, 51(5): 614-621. DOI: 10.11665/j.issn.1000-5048.20200514 |
[6] | TAO Yingjun, WU Jie, LIU Chang. Application of proteomics in diabetes and its complications[J]. Journal of China Pharmaceutical University, 2020, 51(3): 368-373. DOI: 10.11665/j.issn.1000-5048.20200315 |
[7] | YIN Kunpeng, ZHENG Hao, XIE Binxin, LI Ping, ZHANG Lei, FAN Yong, ZHU Wei, QI Lianwen. Clinical metabolomics in diagnosis and therapy of coronary artery disease[J]. Journal of China Pharmaceutical University, 2017, 48(6): 629-634. DOI: 10.11665/j.issn.1000-5048.20170601 |
[8] | ZHANG Xue, WANG Yuhao, ZHENG Yunsi, HE Hua, LIU Xiaoquan. Evaluation of the protective effect of salvianolic acid A on ischemic heart failure by a multi-target pharmacokinetic-pharmacodynamic model[J]. Journal of China Pharmaceutical University, 2016, 47(5): 587-594. DOI: 10.11665/j.issn.1000-5048.20160514 |
[9] | LI Chen, YUAN Linhua, MA Xueqin, LIU Xiaoquan, XI Tao. Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2013, 44(3): 257-262. DOI: 10.11665/j.issn.1000-5048.20130314 |
[10] | HUANG Yin, XU Fengguo, ZHANG Wei, ONG Choonnam, ZHANG Zunjian. Progress for pharmacometabolomics and its applications[J]. Journal of China Pharmaceutical University, 2013, 44(2): 105-112. DOI: 10.11665/j.issn.1000-5048.20130202 |